Bo Grønlund

494 total citations
25 papers, 394 citations indexed

About

Bo Grønlund is a scholar working on Reproductive Medicine, Oncology and Immunology. According to data from OpenAlex, Bo Grønlund has authored 25 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Bo Grønlund's work include Ovarian cancer diagnosis and treatment (14 papers), Renal cell carcinoma treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Bo Grønlund is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Renal cell carcinoma treatment (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Bo Grønlund collaborates with scholars based in Denmark, Sweden and Finland. Bo Grønlund's co-authors include Claus Høgdall, Heine H. Hansen, Svend Aage Engelholm, Svend A. Engelholm, Ib Jarle Christensen, Estrid Høgdall, Lene Lundvall, Jens B. Knudsen, Jørgen Hilden and Niels Juel Christensen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Bo Grønlund

23 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Grønlund Denmark 11 246 159 119 118 77 25 394
W. Stummvoll Austria 9 159 0.6× 83 0.5× 133 1.1× 158 1.3× 70 0.9× 22 459
James Pavelka United States 9 231 0.9× 55 0.3× 242 2.0× 165 1.4× 92 1.2× 14 500
Ingolf Juhasz-Böess Germany 12 105 0.4× 54 0.3× 131 1.1× 96 0.8× 87 1.1× 28 397
Erin A. Blake United States 14 227 0.9× 76 0.5× 208 1.7× 177 1.5× 53 0.7× 31 474
Bo Ma China 6 159 0.6× 66 0.4× 45 0.4× 78 0.7× 95 1.2× 16 326
Michelle L. MacKintosh United Kingdom 11 207 0.8× 54 0.3× 312 2.6× 140 1.2× 90 1.2× 16 493
Anna de Fazio Australia 11 72 0.3× 94 0.6× 35 0.3× 58 0.5× 81 1.1× 22 359
Ayumu Matsuoka Japan 9 103 0.4× 105 0.7× 44 0.4× 92 0.8× 34 0.4× 60 265
Brent J. Tierney United States 11 43 0.2× 137 0.9× 74 0.6× 110 0.9× 94 1.2× 17 386
Hiroaki Soyama Japan 11 85 0.3× 32 0.2× 114 1.0× 97 0.8× 75 1.0× 38 343

Countries citing papers authored by Bo Grønlund

Since Specialization
Citations

This map shows the geographic impact of Bo Grønlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Grønlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Grønlund more than expected).

Fields of papers citing papers by Bo Grønlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Grønlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Grønlund. The network helps show where Bo Grønlund may publish in the future.

Co-authorship network of co-authors of Bo Grønlund

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Grønlund. A scholar is included among the top collaborators of Bo Grønlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Grønlund. Bo Grønlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melgaard, Dorte, et al.. (2014). PP127-MON: The Need for a Special Diet for Elderly Patients with Dysphagia. Clinical Nutrition. 33. S177–S177. 1 indexed citations
2.
Grønlund, Bo, et al.. (2005). Cancer-associated serum antigen level: a novel prognostic indicator for survival in patients with recurrent ovarian carcinoma. International Journal of Gynecological Cancer. 15(5). 836–843. 10 indexed citations
3.
Grønlund, Bo, Svend Aage Engelholm, György Horváth, Johanna Mäenpää, & Mona Ridderheim. (2005). Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum‐taxane. Cancer. 103(7). 1388–1396. 8 indexed citations
4.
Grønlund, Bo, et al.. (2005). Recurrent epithelial ovarian cancer: Validation and improvement of an established prognostic index. European Journal of Obstetrics & Gynecology and Reproductive Biology. 123(1). 98–106. 4 indexed citations
5.
Grønlund, Bo, Heine H. Hansen, Claus Høgdall, Estrid Høgdall, & Svend A. Engelholm. (2004). Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?. British Journal of Cancer. 90(2). 377–382. 15 indexed citations
6.
Grønlund, Bo, Claus Høgdall, Ib Jarle Christensen, Svend Aage Engelholm, & Heine H. Hansen. (2004). Is stabilization of disease a useful indicator for survival in second-line treatment of ovarian carcinoma pre-treated with Paclitaxel–Platinum?. Gynecologic Oncology. 94(2). 409–415. 14 indexed citations
7.
Grønlund, Bo, Lene Lundvall, Ib Jarle Christensen, Jens B. Knudsen, & Claus Høgdall. (2004). Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel–platinum. European Journal of Surgical Oncology. 31(1). 67–73. 53 indexed citations
8.
Grønlund, Bo, Claus Høgdall, Jørgen Hilden, et al.. (2004). Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?. Journal of Clinical Oncology. 22(20). 4051–4058. 66 indexed citations
9.
Grønlund, Bo, Heine H. Hansen, Svend A. Engelholm, Estrid Høgdall, & Claus Høgdall. (2003). Should CA125 Response Criteria be Preferred to Who Criteria in the Monitoring of Second-Line Chemotherapy (SLC) of Epithelial Ovarian Carcinoma (EOC)?. International Journal of Gynecological Cancer. 13. 7–7. 1 indexed citations
10.
Grønlund, Bo, Claus Høgdall, Heine H. Hansen, & Svend Aage Engelholm. (2002). Performance status rather than age is the key prognostic factor in second‐line treatment of elderly patients with epithelial ovarian carcinoma. Cancer. 94(7). 1961–1967. 49 indexed citations
11.
Grønlund, Bo, Heine H. Hansen, Claus Høgdall, & Svend A. Engelholm. (2002). Efficacy of low‐dose topotecan in second‐line treatment for patients with epithelial ovarian carcinoma. Cancer. 95(8). 1656–1662. 21 indexed citations
12.
Grønlund, Bo, Claus Høgdall, Heine H. Hansen, & Svend A. Engelholm. (2001). Results of Reinduction Therapy with Paclitaxel and Carboplatin in Recurrent Epithelial Ovarian Cancer. Gynecologic Oncology. 83(1). 128–134. 57 indexed citations
13.
Grønlund, Bo, Lars Grønlund, & Niels Juel Christensen. (1994). Subcutaneous noradrenaline concentration increase in normal subjects during cold exposure evaluated by microdialysis. Clinical Physiology. 14(4). 467–474. 10 indexed citations
14.
Grønlund, Bo, et al.. (1993). Serial Human Chorionic Gonadotrophin Determination in the Diagnosis of Ectopic Pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 33(3). 312–314. 6 indexed citations
15.
Grønlund, Bo, Lars Grønlund, Arne Astrup, Ping Bie, & N. J. Christensen. (1993). Determination of local catecholamine release by microdialysis.. PubMed. 17 Suppl 3. S60–2; discussion S68. 2 indexed citations
16.
Grønlund, Bo, Lars Grønlund, Sten Madsbad, & Niels Fogh‐Andersen. (1992). Clinical evaluation of a prototype glucose electrode. Biosensors and Bioelectronics. 7(10). 683–687. 2 indexed citations
17.
Grønlund, Bo, et al.. (1991). Effect of Insulin‐induced Hypoglycaemia on Absorption of Unmodified Insulin after Subcutaneous or Intramuscular Injection. Diabetic Medicine. 8(1). 13–17. 3 indexed citations
18.
Grønlund, Bo, Arne Astrup, Peter Bie, & Niels Juel Christensen. (1991). Noradrenaline release in skeletal muscle and in adipose tissue studied by microdialysis. Clinical Science. 80(6). 595–598. 23 indexed citations
19.
Grønlund, Bo, et al.. (1991). Serious intestinal complication five years after insertion of a Nova-T. Contraception. 44(5). 517–521. 8 indexed citations
20.
Grønlund, Bo. (1990). Our daily bread: not so simple for patients with coeliac disease.. 10–11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Stummvoll Breakdown of academic impact, for papers by James Pavelka Breakdown of academic impact, for papers by Ingolf Juhasz-Böess Breakdown of academic impact, for papers by Erin A. Blake Breakdown of academic impact, for papers by Bo Ma Breakdown of academic impact, for papers by Michelle L. MacKintosh Breakdown of academic impact, for papers by Anna de Fazio Breakdown of academic impact, for papers by Ayumu Matsuoka Breakdown of academic impact, for papers by Brent J. Tierney Breakdown of academic impact, for papers by Hiroaki Soyama
Rankless by CCL
2026